PEOPLE ON THE MOVE
Halo
Contract development and manufacturing organisation Halo Pharmaceutical has appointed Lee Karras CEO and Barry Lederman Chief Financial Officer.
Karras has 25 years’ experience in contract pharmaceuticals. Most recently he served as president of IBA Molecular North America, a company manufacturing and distributing radiopharmaceuticals.
Barry Lederman has led teams of several public and private drug companies. Before Halo, he was VP and CFO at Eisa, where he oversaw North and South American operations. He has also held senior roles at Wedgewood Pharmacy, Nycomed US, Qualitrol, and Roche.